Surge in Metabolic and Bariatric Surgery Amid Rise of GLP-1 Receptor Agonists
In a groundbreaking shift within metabolic and bariatric treatment paradigms, recent national data reveal a dramatic rise in prescriptions for ...
In a groundbreaking shift within metabolic and bariatric treatment paradigms, recent national data reveal a dramatic rise in prescriptions for ...
In a groundbreaking synthesis of current clinical evidence, glucagon-like peptide-1 receptor agonists (GLP-1 RAs), originally developed for diabetes management, are ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine